Partner Cheryl Burgess authored, “Supreme Changes for ‘Single-Use’ Patent Law,” which was published in Medical Product Outsourcing. Excerpt: Recent changes to the Patent Exhaustion Doctrine to impact the medical device community. A patent owner…
Partner Kerry Taylor and Associate Clayton Henson co-authored, “ IPR Appeals In 2017: The Outcomes In Remands To PTAB,” which was published in Law360. Excerpt: Inter partes review proceedings before the Patent Trial and Appeal…
Partner Kerry Taylor and Associates Daniel Kamkar and Joel Broussard co-authored, “IPR Appeals In 2017: The Pendency And Success Rates,” which was published in Law360. Excerpt: Inter partes reviews are designed to quickly…
Partner Tom Arno and Associate Loni Marrow co-authored, “Intellectual Property (IP) Basic for Beauty Entrepreneurs,” which was published in Global Cosmetic Industry. Excerpt: Intellectual property (IP) protection is important for every industry, especially…
Attorney Susan M. Natland co-authored “No Likelihood of Confusion Between Chevron Marks” which was published in World Trademark Review Daily. Read the full article below. …
Attorneys Paul Conover and Curtis R. Huffmire authored “Ten Skills Medical Device Companies Need from Their Patent Attorneys” which was published in the December 2016 issue of The MedTech Strategist. Read the full…
In a creative move to take advantage of recent PTAB decisions regarding Sovereign Immunity, (see e.g., Covidien LP v. University of Florida Research Foundation, IPR2016-01274 and Neochord, Inc. v. University…
Attorney Susan M. Natland co-authored “What’s in a Name? TTAB Refuses Registration of OLIN Mark” which was published in World Trademark Review Daily. Read the full article below. …
Partner Jonathan Bachand and Associate Ashley Morales co-authored, “Hatch-Waxman And Copying: An Exception To The Exception?” which was published in Law360. Excerpt: Over a year ago, in a Law360 Expert Analysis article, we set…
Partners Agnes Juang, Ph.D., and Daniel A. Kamkar co-authored, “The Complex Litigation Surrounding Remicade And Its Biosimilar Challengers” which was published in Biosimilar Development. Excerpt: Janssen Biotech Inc. and Celltrion Healthcare are engaged…
